Precirix
PrivateLast Round
Series B
Mar 16, 2022
Total Funding Raised
$129.61M
Company Overview
Precirix is a biotechnology company that develops targeted radiopharmaceuticals for cancer therapy using camelid single-domain antibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Precirix Comparables
Compare Precirix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TwoStep Therapeutics | 84% | |
| Ariceum Therapeutics | 84% | |
| Alpha-9 Oncology | 84% | |
Precirix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 16, 2022 | ||||
| Grant | Jan 1, 2019 | ||||
| Series A | Nov 15, 2018 | ||||
| Seed | Oct 14, 2014 |
Key People
Founding team and executive leadership
Precirix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioMedPartners | Series B, Series A |
| Forbion | Series B |
| Gimv | Series B, Series A |
| Pontifax Venture Capital | Series B, Series A |
| HealthCap | Series B, Series A |
| V-Bio Ventures | Series B, Series A |
| Novo Holdings | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2022
$88M round led by Jeito, Inkef Capital, and Forbion.
- Jan 1, 2019
$8.4K grant received from Innoviris.
Precirix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Precirix's valuation, stock price, and market status.